Niagen Bioscience (NAGE) EBT (2010 - 2026)
Niagen Bioscience (NAGE) posted quarterly EBT of $6.7 million for Q1 2026, up 28.75% year-over-year from $5.2 million in Q1 2025, and up 52.24% quarter-over-quarter from $4.4 million in Q4 2025.
Niagen Bioscience (NAGE) EBT (2010 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has reported EBT for 17 consecutive years, with $6.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT rose 28.75% year-over-year to $6.7 million; the TTM figure through Mar 2026 stood at $19.7 million (up 35.11% YoY), while the FY2025 annual figure was $18.2 million, up 105.44% from the prior year.
- EBT advanced to $6.7 million in Q1 2026 per NAGE's latest filing, from $4.4 million in the prior quarter.
- Across five years, EBT topped out at $7.5 million in Q4 2024 and bottomed at -$11.7 million in Q2 2022.
- Historically, EBT has averaged -$878235.3 across 5 years, with a median of -$270000.0 in 2023.
- On a YoY basis, EBT climbed as much as 25013.33% in 2025 and fell as far as 40.89% in 2025.
- Niagen Bioscience's EBT stood at -$1.6 million in 2022, then surged by 82.9% to -$270000.0 in 2023, then jumped by 2871.85% to $7.5 million in 2024, then slumped by 40.89% to $4.4 million in 2025, then jumped by 52.24% to $6.7 million in 2026.
- Business Quant data shows NAGE's EBT at $6.7 million in Q1 2026, $4.4 million in Q4 2025, and $4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Niagen Bioscience | 238.30 Mn | 171.56 Mn | 19.31 Mn | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Mn |
| Mar 31, 2026 | 6.74 Mn |
| Dec 31, 2025 | 4.42 Mn |
| Sep 30, 2025 | 4.80 Mn |
| Jun 30, 2025 | 3.74 Mn |
| Mar 31, 2025 | 5.23 Mn |
| Dec 31, 2024 | 7.48 Mn |
| Sep 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | -15,000.00 |
| Mar 31, 2024 | -492,000.00 |
| Dec 31, 2023 | -270,000.00 |
| Sep 30, 2023 | -5.39 Mn |
| Jun 30, 2023 | -6.79 Mn |
| Mar 31, 2023 | -6.68 Mn |
| Dec 31, 2022 | -1.58 Mn |
| Sep 30, 2022 | -8.11 Mn |
| Jun 30, 2022 | -11.66 Mn |
| Mar 31, 2022 | -8.23 Mn |
| Dec 31, 2021 | -4.85 Mn |
| Sep 30, 2021 | -9.68 Mn |